Fertoz Limited

As of December 31, 2023, Fertoz Limited has 257.83M shares outstanding.

These figures are as of December 31, 2023. The price-to-sales ratio is 4.58, and the price-to-book ratio stands at 1.93.

These figures are as of December 31, 2023. The EV/Sales ratio of 4.40 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of December 31, 2023, Fertoz Limited maintains a current ratio of 2.78, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2023, Fertoz Limited posted a negative return on equity (ROE) of -54.68, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -32.29, reflecting losses generated across the asset base. Inventory turnover of 2.16 indicates how many times Fertoz Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2023, Fertoz Limited posted a gross margin of 22.62, reflecting its pricing power and cost economics. The operating margin of -145.38 and net profit margin of -160.64 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2023. Total shareholder yield is negative at -14.72, meaning Fertoz Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Fertoz Limited's most recent stock split took place on March 11, 2021 with a 249:256 split ratio.

As of December 31, 2023, Fertoz Limited has an Altman Z-Score of 0.57, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.